Key result
Stage-adapted perioperative prevention of thrombohemorrhagic complications using CHA2DS2-VASc and HEMORR2HAGES scales reduced mortality from 3.6% to 1.2% and decreased the incidence of both bleeding and ischemic events.
Why the study?
The study was conducted to improve the effectiveness of prevention of thrombohemorrhagic disorders in patients with calculous cholecystitis and obstructive jaundice.
Does stage-based prevention using CHA2DS2-VASc and HEMORR2HAGES scales reduce thrombohemorrhagic complications in patients with calculous cholecystitis and obstructive jaundice compared to standard prevention?
Cohort (n=500)
No
Does stage-based prevention using CHA2DS2-VASc and HEMORR2HAGES scales reduce thrombohemorrhagic complications in patients with calculous cholecystitis and obstructive jaundice compared to standard prevention?
Absolute Event Rate: 1.2% vs 3.6%
Absolute Risk Reduction: 2.4%
Tailoring perioperative thrombohemorrhagic prophylaxis to the specific stage of obstructive jaundice using CHA2DS2-VASc and HEMORR2HAGES scales may reduce both bleeding and thrombotic complications.
Hypothesis-generating for stage-adapted perioperative strategies; requires randomized trials before practice change.
The OBJECTIVE was to improve the effectiveness of prevention of thrombohemorrhagic disorders in patients with calculous cholecystitis and obstructive jaundice. METHODS AND MATERIALS . The clinic examined 537 patients operated on for obstructive jaundice. From 2010 to 2015, the prevention of thrombohemorrhagic complications consisted in the determination of risk factors, elastic compression of the lower extremities and the appointment of anticoagulants (1st comparative group). Since 2015, all medical measures have also been carried out taking into account the stages of obstructive jaundice (2nd study group). RESULTS. When comparing the results, the number of subhepatic abscessed hematomas decreased from 4 (1.6 %) patients in the first group to 2 (0.8 %) in the second, the number of gastric bleedings-from 6 (2.4 %) to 3 (1.2 %), metrorrhagia – from 3 (1.2 %) to 1 (0.4 %), pancreatic necrosis – from 8 (3.2 %) to 5 (1.9 %), pulmonary embolism – from 7 (2.8 %) to 5 (2.0 %), the number of strokes and transient disorders of cerebral circulation – from 5 (2.0 %) to 3 (1.2 %), the number of cardiac arrhythmias in the form of atrial fibrillation-from 3 (1.2 %) to 2 (0.8 %). The incidence of myocardial infarction decreased from 5 (2.0 %) patients to 3 (1.2 %), and the incidence of mesenteric vascular thrombosis decreased from 3 (1.2 %) to 1 (0.4 %). In group 1, 2 (0.8 %) patients had hemobilia. CONCLUSION. In addition to protocols and standards, the prevention of thrombohemorrhagic complications should take into account the stages of obstructive jaundice. During the period of cholestasis, the prevention of thrombohemorrhagic complications should be used in the same volume as in the absence of jaundice. In hepatocytolysis, it should be performed using the CHA 2 DS 2 -VASc scale with the HEMORR 2 HAGESscale as a safety net. In cholangitis, on the contrary, the main role is assigned to the HEMORR 2 HAGESscale.
No takes yet. Share an insight, caveat, or question.
Федоров et al. (2022) conducted a cohort in Calculous cholecystitis and obstructive jaundice (n=500). Stage-adapted thrombohemorrhagic prophylaxis using CHA2DS2-VASc and HEMORR2HAGES scales vs. Standard prophylaxis (elastic compression and anticoagulants) was evaluated on Mortality. Stage-adapted perioperative prevention of thrombohemorrhagic complications using CHA2DS2-VASc and HEMORR2HAGES scales reduced mortality from 3.6% to 1.2% and decreased the incidence of both bleeding and ischemic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: